查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
传染病体外诊断的市场规模、份额和趋势分析报告：按产品（设备、试剂）、按应用（HPV、HIV）、按技术、按测试站点、按细分市场，2022-2030 年
市场调查报告书
商品编码
1122233

传染病体外诊断的市场规模、份额和趋势分析报告：按产品（设备、试剂）、按应用（HPV、HIV）、按技术、按测试站点、按细分市场，2022-2030 年

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Application (HPV, HIV), By Technology, By Test Location, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

传染病体外诊断市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年，全球传染病体外诊断市场规模将达到 566 亿美元，2022 年至 2030 年的复合年增长率为 -7.4%。结核病和 COVID-19 等传染病的日益流行以及技术进步预计将推动未来几年的产品需求。耐多药感染的增加正在加强对传染病的早期诊断。例如，MDR 感染在 ICU 患者中非常常见，而根据 2021 年《Microbial Drug Resistance Journal》，重症 SARS-CoV-2 患者的 MDR 感染患病率在 14% 到 50% 之间。

传染病的诊断前诊断和抗生素治疗的延误进一步加剧了耐药细菌的传播，为行业发展创造了有利可图的机会。该行业已推出大量产品以满足消费者的需求。例如，2022 年 5 月，BD 在美国宣布了一个传染病自动诊断平台。该系统可装载 1700 个样品，并且无需进行样品分类，从而减少错误。各种竞争对手提供的产品具有战略性定价，以增加竞争对手之间的竞争。

然而，POC测试和实验室测试有着不同的敏感性和认知，当消费者不得不在两者之间做出选择时，购买行为的复杂性就变得显而易见。该行业为寡头垄断，Hoffmann-La Roche Ltd.、Alere、bioMerieux 和 BD 等公司共同持有大部分市场份额。全球行业对价格敏感，在生产具有成本效益和高效的产品方面造成参与者之间的激烈竞争。由于预计将推出新型生物标誌物试剂盒，预计竞争对手之间的竞争将在预测期内加剧。竞争对手正在采取重要策略，例如产品发布和教育活动，以获取更高的市场份额。

传染病体外诊断市场报告亮点

由于在测试中大量使用，试剂产品部门在 2021 年占最大的收入份额。

分子诊断领域在 2021 年占最大份额，原因是该领域的产品发布数量增加，并且由于高精度而采用率增加。

按应用划分，COVID-19 细分市场在 2021 年主导了行业，在检测方面的支出很高，以遏制病毒的传播

与 PoC 和家庭测试相比，中心实验室部分更可靠，因为基于实验室的测试具有更高的准确性，并且这些测试与其他两个部分相比具有竞争力。，在 2021 年占最高收入份额

由于良好的监管框架、专注于预防和早期检测以及该地区对新型诊断方法的高度采用，北美在 2021 年主导了全球行业

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 产品
    • 技术
    • 应用
    • 测试地点
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
      • 北美初级面试数据
      • 来自欧洲的初步访谈数据
      • 亚太地区主要访谈数据
      • 中东和非洲的主要采访数据
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析（模型一）
      • 方法一：商品流动方法
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场展望
  • 细分洞察
  • 竞争考虑

3. 体外诊断市场的变量、趋势和范围

  • 市场系列展望
    • 母公司的市场前景
  • 绘製渗透率和增长前景
  • 用户视角分析
    • 消费者行为分析
    • 市场影响者分析
    • 关键最终用户列表
  • 监管框架
  • 市场动态
    • 市场驱动力分析
      • 老年人口不断增长
      • 技术进步
      • 对 PoC 设施的高需求
      • 传染病的传播
      • 研发活动的外部资金
    • 市场约束分析
      • IVD 测试的高价格
    • 行业挑战
      • 存在模糊的监管框架
  • 传染病体外诊断市场分析工具
    • 行业分析——波特五力
    • 杵分析
    • 重大交易和战略联盟分析
      • 新产品发布
      • 併购
      • 扩张
      • 合伙
      • 营销和推广
    • 市场进入策略

第 4 章传染病体外诊断市场细分分析，按产品，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年产品类型市场份额分析
  • 细分仪表板
  • 2018-2030年按产品分列的全球体外诊断市场
  • 市场规模和预测，趋势分析，2018-2030
    • 机器
    • 试剂
    • 软件

第 5 章传染病体外诊断市场细分分析，按技术，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年技术类型市场份额分析
  • 细分仪表板
  • 2018-2030 年按技术分列的全球传染病体外诊断市场
  • 市场规模和预测，趋势分析，2018-2030
    • 免疫测定
    • 分子诊断
      • 聚合□炼式反应 (PCR)
      • 原位杂交
      • 等温核酸扩增技术 (INAAT)
      • 芯片和微阵列
      • 测序和NGS
      • 转录介导的扩增
      • 其他
    • 微生物学
    • 其他

6. 按应用分列的传染病体外诊断市场细分分析，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年应用类型市场份额分析
  • 细分仪表板
  • 2018-2030 年按应用分列的全球传染病体外诊断市场
  • 市场规模和预测，趋势分析，2018-2030
    • 耐甲氧西林金黄色葡萄球菌
    • 链球菌
    • 艰难梭菌
    • 耐万古霉素肠球菌（VRE）
    • 耐碳青霉烯类肠道细菌试验（CRE）
    • 呼吸道病毒
    • 念珠菌
    • 结核病 (TB) 和耐药结核病
    • 胃肠道 (GI) 小组测试
    • 衣原体
    • 淋病
    • 人乳头瘤病毒 (HPV)
    • 人类免疫缺陷病毒 (HIV)
    • 丙型肝炎
    • 乙型肝炎
    • 新冠肺炎）
    • 其他

7. 传染病体外诊断市场细分分析，按测试地点，2018-2030 年（百万美元）

  • 定义和范围
  • 2021 年和 2030 年测试位置类型的市场份额分析
  • 细分仪表板
  • 全球传染病体外诊断市场，按测试地点，2018-2030
  • 市场规模和预测，趋势分析，2018-2030
    • 注意事项
    • 中央研究院
    • 其他

8. 2018-2030 年按地区分列的传染病体外诊断市场细分分析（百万美元）

  • 定义和范围
  • 2021 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场快照
  • 2021 年区域市场份额和主要参与者
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • SWOT分析
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2021-2030 年市场规模、预测、收入、趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多边环境协定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 9 章 竞争格局

  • 主要市场参与者的最新发展和影响分析
    • 安索夫矩阵
    • 热图分析
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
    • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 公司市场分析
    • 2021年各地区公司市场份额
    • 竞争仪錶盘分析
      • 市场差异化因素
  • 民营企业
    • 主要初创企业名单
  • 公司简介
    • BD
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • bioMerieux SA
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Abbott
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Quidel Corporation
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • OraSure Technologies, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Hologic Inc. (Gen-Probe)
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Cepheid（Danaher）
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • QIAGEN
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • F. Hoffmann-La Roche Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Siemens Healthcare GmbH
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Bio-Rad Laboratories, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: 978-1-68038-716-2

Infectious Disease In Vitro Diagnostics Market Growth & Trends:

The global infectious disease in vitro diagnostics market size is expected to reach USD 56.60 billion by 2030, registering a CAGR of -7.4% from 2022 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.

The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.

However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMerieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.

Infectious Disease In Vitro Diagnostics Market Report Highlights:

  • The reagents product segment held the largest revenue share in 2021 owing to its high volume usage in testing
  • The molecular diagnostics segment held the largest share in 2021 owing to an increased number of product launches in the segment and increased adoption due to its high accuracy
  • By application, the COVID-19 segment dominated the industry in 2021 due to the high expenditure on testing, to reduce the spread of the virus
  • The central laboratories segment held the highest revenue share in 2021 due to the higher accuracy of laboratory-based tests, which makes them more reliable as compared to PoC and home tests, giving these tests a competitive edge over the other two segments
  • North America dominated the global industry in 2021 due to its favorable regulatory framework, focus on preventive & early testing, and the higher adoption rate of novel diagnostics in this region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Technology
    • 1.1.3 Application
    • 1.1.4 Test Location
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for primary interviews in Europe
      • 1.3.5.3 Data for primary interviews in Asia Pacific
      • 1.3.5.4 Data for primary interviews in Middle East and Africa
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Insights
  • 2.3 Competitive Insights

Chapter 3 IVD Infectious Disease Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer behavior analysis
    • 3.3.2 Market influencer analysis
    • 3.3.3 List of key end users
  • 3.4 Regulatory Framework
  • 3.5 Market Dynamics
    • 3.5.1 Market driver analysis
      • 3.5.1.1 Growing geriatric population
      • 3.5.1.2 Technological advancements
      • 3.5.1.3 High demand for PoC facilities
      • 3.5.1.4 Increasing prevalence of infectious diseases
      • 3.5.1.5 External funding for R&D activities
    • 3.5.2 Market restraint analysis
      • 3.5.2.1 High prices of IVD tests
    • 3.5.3 Industry challenges
      • 3.5.3.1 Presence of ambiguous regulatory framework
  • 3.6 IVD Infectious Disease Market Analysis Tools
    • 3.6.1 Industry Analysis - Porter's Five Forces
    • 3.6.2 PESTLE Analysis
    • 3.6.3 Major deals and strategic alliances analysis
      • 3.6.3.1 New product launch
      • 3.6.3.2 Mergers and acquisitions
      • 3.6.3.3 Expansion
      • 3.6.3.4 Partnerships
      • 3.6.3.5 Marketing & promotions
    • 3.6.4 Market entry strategies

Chapter 4 IVD Infectious Diseases Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Product Type Market Share Analysis, 2021 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global IVD Infectious Diseases Market, by Product, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Instruments
      • 4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.2 Reagents
      • 4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.5.3 Software
      • 4.5.3.1 Software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 IVD Infectious Diseases Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Technology Type Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global IVD Infectious Diseases Market, by Technology, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Immunoassay
      • 5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Molecular Diagnostics
      • 5.5.2.1 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.3 Polymerase Chain Reaction (PCR)
      • 5.5.2.3.1 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.4 In Situ Hybridization
      • 5.5.2.4.1 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
      • 5.5.2.5.1 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.6 Chips and Microarrays
      • 5.5.2.6.1 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.7 Sequencing & NGS
      • 5.5.2.7.1 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.8 Transcription Mediated Amplification
      • 5.5.2.8.1 Transcription mediated amplification market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.5.2.9 Others
      • 5.5.2.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Microbiology
      • 5.5.3.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.5.4 Others
      • 5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 IVD Infectious Diseases Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 Application Type Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global IVD Infectious Diseases Market, by Application, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 MRSA
      • 6.5.1.1 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Streptococcus
      • 6.5.2.1 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3 Clostridium Difficile
      • 6.5.3.1 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4 Vancomycin-resistant Enterococci (VRE)
      • 6.5.4.1 VRE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5 Carbapenem-resistant Enterobacterial Testing (CRE)
      • 6.5.5.1 CRE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6 Respiratory Virus
      • 6.5.6.1 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7 Candida
      • 6.5.7.1 Candida market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.8 Tuberculosis (TB) & Drug-resistant TB
      • 6.5.8.1 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.9 Gastrointestinal (GI) Panel Testing
      • 6.5.9.1 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.10 Chlamydia
      • 6.5.10.1 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.11 Gonorrhea
      • 6.5.11.1 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.12 Human papillomavirus (HPV)
      • 6.5.12.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.13 Human immunodeficiency virus (HIV)
      • 6.5.13.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.14 Hepatitis C
      • 6.5.14.1 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.15 Hepatitis B
      • 6.5.15.1 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.16 COVID-19
      • 6.5.16.1 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.17 Others
      • 6.5.17.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 IVD Infectious Diseases Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Million)

  • 7.1 Definition and Scope
  • 7.2 Test Location Type Market Share Analysis, 2021 & 2030
  • 7.3 Segment Dashboard
  • 7.4 Global IVD Infectious Diseases Market, by Test Location, 2018 to 2030
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.5.1 Point of Care
      • 7.5.1.1 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2 Central Laboratories
      • 7.5.2.1 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Others
      • 7.5.3.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 IVD Infectious Diseases Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Definition & Scope
  • 8.2 Regional Market Share Analysis, 2021 & 2030
  • 8.3 Regional Market Dashboard
  • 8.4 Regional Market Snapshot
  • 8.5 Regional Market Share and Leading Players, 2021
    • 8.5.1 North America
    • 8.5.2 Europe
    • 8.5.3 Asia Pacific
    • 8.5.4 Latin America
    • 8.5.5 Middle East and Africa
  • 8.6 SWOT Analysis
    • 8.6.1 North America
    • 8.6.2 Europe
    • 8.6.3 Asia Pacific
    • 8.6.4 Latin America
    • 8.6.5 Middle East and Africa
  • 8.7 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
    • 8.7.1 North America
      • 8.7.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.1.2 U.S.
      • 8.7.1.2.1 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.1.3 Canada
      • 8.7.1.3.1 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.2 Europe
      • 8.7.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.2 U.K.
      • 8.7.2.2.1 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.3 Germany
      • 8.7.2.3.1 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.4 Spain
      • 8.7.2.4.1 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.5 France
      • 8.7.2.5.1 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.2.6 Italy
      • 8.7.2.6.1 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.3 Asia Pacific
      • 8.7.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.2 Japan
      • 8.7.3.2.1 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.3 China
      • 8.7.3.3.1 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.4 India
      • 8.7.3.4.1 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.5 South Korea
      • 8.7.3.5.1 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.3.6 Australia
      • 8.7.3.6.1 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.4 Latin America
      • 8.7.4.1 Latin America market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.2 Brazil
      • 8.7.4.2.1 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.3 Mexico
      • 8.7.4.3.1 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.4.4 Argentina
      • 8.7.4.4.1 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.7.5 MEA
      • 8.7.5.1 MEA market estimates and forecast estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.2 South Africa
      • 8.7.5.2.1 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.3 Saudi Arabia
      • 8.7.5.3.1 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.7.5.4 UAE
      • 8.7.5.4.1 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 9.1.1 Ansoff matrix
    • 9.1.2 Heat map analysis
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
  • 9.3 Vendor Landscape
    • 9.3.1 List of key distributors and channel partners
    • 9.3.2 Key customers
    • 9.3.3 Key company market share analysis, 2021
  • 9.4 Public Companies
    • 9.4.1 Company market position analysis
    • 9.4.2 Company market share, by region, 2021
    • 9.4.3 Competitive dashboard analysis
      • 9.4.3.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List of key emerging companies
  • 9.6 Company Profiles
    • 9.6.1 BD
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial performance
      • 9.6.1.3 Product benchmarking
      • 9.6.1.4 Strategic initiatives
    • 9.6.2 bioMerieux SA
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 Abbott
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 Quidel Corporation
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 OraSure Technologies, Inc
      • 9.6.5.1 Company overview
      • 9.6.5.2 Financial performance
      • 9.6.5.3 Product benchmarking
      • 9.6.5.4 Strategic initiatives
    • 9.6.6 Hologic Inc. (Gen-Probe)
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial performance
      • 9.6.6.3 Product benchmarking
      • 9.6.6.4 Strategic initiatives
    • 9.6.7 Cepheid (Danaher)
      • 9.6.7.1 Company overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product benchmarking
      • 9.6.7.4 Strategic initiatives
    • 9.6.8 QIAGEN
      • 9.6.8.1 Company overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product benchmarking
      • 9.6.8.4 Strategic initiatives
    • 9.6.9 F. Hoffmann-La Roche Ltd.
      • 9.6.9.1 Company overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 Siemens Healthcare GmbH
      • 9.6.10.1 Company overview
      • 9.6.10.2 Financial performance
      • 9.6.10.3 Product benchmarking
      • 9.6.10.4 Strategic initiatives
    • 9.6.11 Bio-Rad Laboratories, Inc.
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 50 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 51 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 52 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 53 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 54 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 55 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 56 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 57 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 58 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 59 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 60 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 61 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 62 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 63 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 64 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 65 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 66 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 67 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 68 Singapore IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 69 Singapore IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 70 Singapore IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 71 Singapore IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 72 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 73 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 74 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 75 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 76 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 77 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 78 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 79 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 80 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 81 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 82 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 83 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 84 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 85 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 86 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 87 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 88 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 89 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 90 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 91 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 92 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 93 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 94 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 95 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 96 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 97 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 98 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 99 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 100 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 101 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 102 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 103 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 104 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 105 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)
  • TABLE 106 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 107 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Million)
  • TABLE 108 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 109 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 IVD infectious diseases market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Primary interviews in North America
  • FIG. 6 Primary interviews in Europe
  • FIG. 7 Primary interviews in Asia Pacific
  • FIG. 8 Primary interviews in Middle East and Africa
  • FIG. 9 Market research approaches
  • FIG. 10 Value-chain-based sizing & forecasting
  • FIG. 11 QFD modeling for market share assessment
  • FIG. 12 Market formulation & validation
  • FIG. 13 IVD infectious disease market snapshot
  • FIG. 14 Segment Insights
  • FIG. 15 Strategy framework
  • FIG. 16 Penetration & growth prospect mapping
  • FIG. 17 Consumer behavior analysis
  • FIG. 18 Factors influencing North America IVD infectious diseases market (%)
  • FIG. 19 Factors influencing Europe IVD infectious diseases market (%)
  • FIG. 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
  • FIG. 21 Factors influencing Latin America IVD infectious diseases market (%)
  • FIG. 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
  • FIG. 23 Market driver relevance analysis (Current & future impact)
  • FIG. 24 Global population growth, by age group, 2012 - 2021 (Million)
  • FIG. 25 Global percentage of the population, by age group, 2000 and 2050
  • FIG. 26 General trend of CLIA-waived tests
  • FIG. 27 Market restraint relevance analysis (Current & future impact)
  • FIG. 28 Porter's five forces analysis
  • FIG. 29 PESTLE analysis
  • FIG. 30 Strategy mapping
  • FIG. 31 IVD infectious diseases market: Product movement analysis
  • FIG. 32 Product segment dashboard
  • FIG. 33 IVD infectious diseases market product outlook: Key takeaways
  • FIG. 34 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 35 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 36 Software market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 37 IVD infectious diseases market: Technology movement analysis
  • FIG. 38 Technology segment dashboard
  • FIG. 39 IVD infectious diseases market technology outlook: Key takeaways
  • FIG. 40 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 42 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 43 In Situ Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 44 Isothermal Nucleic Acid Amplification Technology (INAAT) market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 45 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 46 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 47 Transcription Mediated Amplification market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 48 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 51 IVD infectious diseases market: Technology movement analysis
  • FIG. 52 Application segment dashboard
  • FIG. 53 IVD infectious diseases market technology outlook: Key takeaways
  • FIG. 54 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 55 Streptococcus market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 56 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 57 VRE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 58 CRE market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 59 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 60 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 61 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 62 GI panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 63 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 64 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 65 HPV market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 66 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 67 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 68 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 69 COVID-19 market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 71 IVD infectious diseases market: Test location movement analysis
  • FIG. 72 Test location segment dashboard
  • FIG. 73 IVD infectious diseases market test location outlook: Key takeaways
  • FIG. 74 Point of Care market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 75 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 76 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 77 Regional outlook, 2021 & 2030
  • FIG. 78 Regional market dashboard
  • FIG. 79 Regional marketplace: Key takeaways
  • FIG. 80 North America market share and leading players, 2021
  • FIG. 81 Europe market share and leading players, 2021
  • FIG. 82 Asia Pacific market share and leading players, 2021
  • FIG. 83 Latin America market share and leading players, 2021
  • FIG. 84 Middle East and Africa market share and leading players, 2021
  • FIG. 85 North America, SWOT
  • FIG. 86 Europe, SWOT
  • FIG. 87 Asia Pacific, SWOT
  • FIG. 88 Latin America, SWOT
  • FIG. 89 Middle East and Africa, SWOT
  • FIG. 90 North America
  • FIG. 91 North America IVD infectious diseases market, 2018 - 2030 (USD Million)
  • FIG. 92 U.S.
  • FIG. 93 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 94 Canada
  • FIG. 95 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 96 Europe
  • FIG. 97 Europe IVD infectious diseases market, 2018 - 2030 (USD Million)
  • FIG. 98 U.K.
  • FIG. 99 U.K. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 100 Germany
  • FIG. 101 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 102 Spain
  • FIG. 103 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 104 France
  • FIG. 105 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 106 Italy
  • FIG. 107 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 108 Asia Pacific
  • FIG. 109 Asia Pacific IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 110 Japan
  • FIG. 111 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 112 China
  • FIG. 113 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 114 India
  • FIG. 115 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 116 South Korea
  • FIG. 117 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 118 Australia
  • FIG. 119 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 120 Latin America
  • FIG. 121 Latin America IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 122 Brazil
  • FIG. 123 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 124 Mexico
  • FIG. 125 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 126 Argentina
  • FIG. 127 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 128 MEA
  • FIG. 129 MEA IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 130 South Africa
  • FIG. 131 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 132 Saudi Arabia
  • FIG. 133 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 134 UAE
  • FIG. 135 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • FIG. 136 Ansoff Matrix
  • FIG. 137 Heat map analysis
  • FIG. 138 Company market share analysis
  • FIG. 139 Company market position analysis
  • FIG. 140 Company market share, by region, 2021
  • FIG. 141 Market differentiators